Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC.BIO, BIOB · Entity 2247 | EVP and CFO | December 14, 2018 | December 17, 2018 |
| Envista Holdings CorpNVST · Entity 4007 | Director | May 19, 2026 | May 21, 2026 |
| Telesis Bio Inc.TBIO · Entity 15606 | Director | July 06, 2023 | May 03, 2024 |
| Varex Imaging CorpVREX · Entity 5135 | Director | February 12, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-RAD LABORATORIES, INC.
Report date December 14, 2018 · Filed December 17, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 6,683.0979 |
Reported balance
After 2018-12-14 transaction · row 1
1 source rowRow 1 · 2018-12-14 · Sale · Disposed 1,411 · Balance 6,683.0979 |
Envista Holdings Corp
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 59,930 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 9,330 · Balance 59,930 F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
Telesis Bio Inc.
Report date July 06, 2023 · Filed May 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 104,491 |
Ending reported balance
After 2024-05-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-07-06 · Grant · Acquired 46,752 · Balance 67,382 F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through such date, 100% of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Row 2 · 2024-05-01 · Grant · Acquired 37,109 · Balance 104,491 F2: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through each applicable date, 16,868 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.54 · Expires 2033-07-06 | Direct | 70,129 |
Reported balance
After 2023-07-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-07-06 · Grant · Acquired 70,129 · Balance 70,129 F3: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.36 · Expires 2034-05-01 | Direct | 30,362 |
Reported balance
After 2024-05-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-05-01 · Grant · Acquired 30,362 · Balance 30,362 F3: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through such date, 100% of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
F2: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through each applicable date, 16,868 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
F3: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
Varex Imaging Corp
Report date February 12, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,331 |
Reported balance
After 2026-02-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-12 · Grant · Acquired 12,331 · Balance 12,331 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.
F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ONTO INNOVATION INC.
Report date May 21, 2025 · Filed May 23, 2025
Section 16 reporting ended · disclosed 2025-05-23. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 21, 2026 20:37 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001278861-26-000008 · wk-form4_1779395841.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,930 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 21:07 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 12,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000026 · wk-form4_1771016873.xml · derivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,331 Underlying: Common Stock · 12,331 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 21:13 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 8,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001278861-26-000004 · wk-form4_1770671631.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 21:13 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 8,483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001278861-26-000004 · wk-form4_1770671631.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:55 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 10,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031063 · wk-form4_1749761708.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,600 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| February 13, 2025 Filed Feb 15, 2025 00:05 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 6,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000031 · wk-form4_1739577895.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,573 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units were issued on February 10, 2022, vested on February 9, 2023, and delivery of the vested Deferred Stock Units, in the form of common stock, occurred on February 13, 2025, the date of the Issuer's 2025 Annual Meeting. F3 · derivative.expiration_date: These Deferred Stock Units were issued on February 10, 2022, vested on February 9, 2023, and delivery of the vested Deferred Stock Units, in the form of common stock, occurred on February 13, 2025, the date of the Issuer's 2025 Annual Meeting. Read SEC document |
| February 13, 2025 Filed Feb 15, 2025 00:05 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 12,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000031 · wk-form4_1739577895.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,123 Underlying: Common Stock · 12,123 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 13, 2025 Filed Feb 15, 2025 00:05 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 6,573 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-25-000031 · wk-form4_1739577895.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| May 22, 2024 Filed May 23, 2024 20:28 UTC | ONTO INNOVATION INC. ONTO · Entity 3340 | GrantCommon Stock | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0002022859-24-000020 · edgardoc.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,918 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), each of which represents a contingent right to receive one (1) share of ONTO Common Stock. 100% of the shares of Common Stock subject to the RSU vest one (1) year from the grant date. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:32 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 10,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000049 · wk-form4_1716496330.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,150 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 01, 2024 Filed May 3, 2024 19:12 UTC | Telesis Bio Inc. TBIO · Entity 15606 | GrantStock Option (right to buy) · Derivative | 30,362 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950170-24-053134 · ownership.xml · derivative · entry 4 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,362 Underlying: Common Stock · 30,362 shares Expires 2034-05-01 F3 · derivative.exercise_date: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Read SEC document |
| May 01, 2024 Filed May 3, 2024 19:12 UTC | Telesis Bio Inc. TBIO · Entity 15606 | GrantCommon Stock | 37,109 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053134 · ownership.xml · nonDerivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,491 F2 · shares: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through each applicable date, 16,868 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 22:04 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 6,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000024 · wk-form4_1707775445.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 22:04 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 6,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000024 · wk-form4_1707775445.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:04 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 9,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000024 · wk-form4_1707775445.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,643 Underlying: Common Stock · 9,643 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| July 06, 2023 Filed May 3, 2024 19:12 UTC | Telesis Bio Inc. TBIO · Entity 15606 | GrantStock Option (right to buy) · Derivative | 70,129 | $0.00 Strike: $1.54 | $0.00 |
DisclosureSEC source: 0000950170-24-053134 · ownership.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,129 Underlying: Common Stock · 70,129 shares Expires 2033-07-06 F3 · derivative.exercise_date: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Read SEC document |
| July 06, 2023 Filed May 3, 2024 19:12 UTC | Telesis Bio Inc. TBIO · Entity 15606 | GrantCommon Stock | 46,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053134 · ownership.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,382 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through such date, 100% of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:34 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 5,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-23-000045 · wf-form4_168504687108690.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,065 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:17 UTC | ONTO INNOVATION INC. ONTO · Entity 3340 | GrantCommon Stock | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001257815-23-000051 · edgardoc.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,109 F1 · security: The Reporting Person was granted restricted stock units ("RSUs"), each of which represents a contingent right to receive one (1) share of ONTO Common Stock. F2 · shares: 100% of the shares of Common Stock subject to the RSU vest one (1) year from the grant date. Generally, vested shares will be delivered to the reporting person as soon as practicable after vesting. Read SEC document |
| February 13, 2023 Filed Feb 13, 2023 22:27 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000030 · wf-form4_167632723409578.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 13, 2021. There was an inadvertently discrepancy in the originally filed Form 4 that showed the distribution date as February 15, 2023. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 13, 2023. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 13, 2021. There was an inadvertently discrepancy in the originally filed Form 4 that showed the distribution date as February 15, 2023. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 13, 2023. Read SEC document |
| February 13, 2023 Filed Feb 13, 2023 22:27 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 6,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000030 · wf-form4_167632723409578.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:27 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 8,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000030 · wf-form4_167632723409578.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,483 Underlying: Common Stock · 8,483 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 18:09 UTC | Telesis Bio Inc. DNAY · Entity 15606 | GrantStock Option (right to buy) · Derivative | 30,945 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0001850079-22-000049 · wf-form4_165515817203218.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,945 Underlying: Common Stock · 30,945 shares Expires 2032-06-09 F2 · derivative.exercise_date: Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Sock Incentive Plan) through each such date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the Grant Date or (ii) the day prior to the date of the annual meeting of the Issuer's shareholders next following the Grant Date. "Grant Date" shall mean June 9, 2022. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 18:09 UTC | Telesis Bio Inc. DNAY · Entity 15606 | GrantCommon Stock | 20,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001850079-22-000049 · wf-form4_165515817203218.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,630 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Codex DNA, Inc.'s (the "Issuer") Common Stock. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Sock Incentive Plan) through each such date, one hundred percent (100%) of the RSUs shall vest on the earlier of (i) the one-year anniversary of the Grant Date or (ii) the day prior to the date of the annual meeting of the Issuer's shareholders next following the Grant Date. "Grant Date" shall mean June 9, 2022. Read SEC document |
| May 24, 2022 Filed May 31, 2022 20:30 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 4,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-22-000074 · wf-form4_165402902143846.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,640 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:51 UTC | ONTO INNOVATION INC. ONTO · Entity 3340 | GrantCommon Stock | 2,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001407682-22-000055 · edgardoc.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,909 F1 · security: Each Restricted Stock Unit represents a contingent right to receive one (1) share of ONTO Common Stock. F2 · shares: 100% of the shares of Common Stock subject to the Restricted Stock Unit vest one (1) year from the grant date. Generally, vested shares will be delivered to the reporting person as soon as practicable after vesting. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 00:16 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 5,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000022 · wf-form4_164488415846600.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,098 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 00:16 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 5,098 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000022 · wf-form4_164488415846600.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 00:16 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 6,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000022 · wf-form4_164488415846600.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,573 Underlying: Common Stock · 6,573 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:55 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 4,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-21-000083 · wf-form4_162214884848533.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,205 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the date of the Issuer's 2022 Annual Meeting of Stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. RSUs are payable in shares of common stock on a one-to-one basis. F2 · balance_after: Includes 16,185 RSUs that were previously reported in Table II. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:08 UTC | ONTO INNOVATION INC. ONTO · Entity 3340 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001407682-21-000084 · edgardoc.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,809 F1 · security: Each Restricted Stock Unit represents a contingent right to receive one (1) share of ONTO Common Stock. F2 · shares: 100% of the shares of Common Stock subject to the Restricted Stock Unit vest one (1) year from the grant date. Generally, vested shares will be delivered to the reporting person as soon as practicable after vesting. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 01:03 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000022 · wf-form4_161352379012375.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 15, 2019. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 15, 2021. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 15, 2019. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 15, 2021. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 01:03 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 6,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000022 · wf-form4_161352379012375.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,881 Underlying: Common Stock · 6,881 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2024 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2024 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 01:03 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 4,312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-21-000022 · wf-form4_161352379012375.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| May 27, 2020 Filed May 29, 2020 20:26 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantRestricted Stock Unit · Derivative | 8,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001377 · form4-05292020_010513.xml · derivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,230 Underlying: Common Stock · 8,230 shares Expires 2030-05-26 F1 · derivative.exercise_price: Restricted stock units are payable in shares of common stock on a one-to-one basis. F2 · derivative.exercise_date: The restricted stock units granted will vest on the date of the Issuer's 2021 annual meeting of stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the issuer. Read SEC document |
| May 12, 2020 Filed May 14, 2020 16:32 UTC | ONTO INNOVATION INC. ONTO · Entity 3340 | GrantCommon Stock | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001407682-20-000078 · edgardoc.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,309 F1 · security: Each Restricted Stock Unit represents a contingent right to receive one (1) share of ONTO Common Stock. F2 · shares: 100% of the shares of Common Stock subject to the Restricted Stock Unit vest one (1) year from the grant date. Generally, vested shares will be delivered to the reporting person as soon as practicable after vesting. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 01:01 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 5,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000015 · wf-form4_158207405349647.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested in four equal quarterly installments over a 12 month period beginning February 16, 2017. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2020. F3 · derivative.expiration_date: These Deferred Stock Units vested in four equal quarterly installments over a 12 month period beginning February 16, 2017. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2020. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 01:01 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 5,148 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-20-000015 · wf-form4_158207405349647.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 13, 2020 Filed Feb 19, 2020 01:01 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000015 · wf-form4_158207405349647.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,160 Underlying: Common Stock · 6,160 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| May 22, 2019 Filed May 24, 2019 00:29 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | GrantCommon Stock | 4,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032525 · doc4.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,509 F1 · shares: Shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of NANO common stock. The restricted stock units vest the sooner of May 22, 2020 or the next annual shareholder's meeting. Read SEC document |
| February 14, 2019 Filed Feb 20, 2019 00:58 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 5,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000027 · wf-form4_155062429536761.xml · derivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,098 Underlying: Common Stock · 5,098 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 3 years from grant date, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 3 years from grant date, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| December 14, 2018 Filed Dec 17, 2018 16:20 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 1,411 | $248.00 | $349,928.00 |
DisclosureSEC source: 0001315406-18-000013 · edgar.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,683.0979 Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:17 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000085 · edgar.xml · derivative · entry 4 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Bio-Rad A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:17 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 160 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000085 · edgar.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:17 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 229 | $308.37 | $70,616.73 |
DisclosureSEC source: 0001652252-18-000085 · edgar.xml · nonDerivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094.0979 Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:17 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 660 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000085 · edgar.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,323.0979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 21:00 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000066 · edgar.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Bio-Rad A Common Stock · 400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 21:00 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 139 | $308.00 | $42,812.00 |
DisclosureSEC source: 0001652252-18-000066 · edgar.xml · nonDerivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,663.0979 Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 21:00 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000066 · edgar.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,802.0979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 18:43 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000054 · edgar.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Bio-Rad A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 7, 2017. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 7, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.